Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

Abstract Background Intravenous immunoglobulin (IVIG) has been used as an immunomodulatory therapy to counteract severe systemic inflammation in coronavirus disease 2019 (COVID-19). But its use in COVID-19 related acute respiratory distress syndrome (ARDS) is not well established. Methods We conduct...

Full description

Saved in:
Bibliographic Details
Main Authors: Husain S. Ali, Moustafa S. Elshafei, Mohamed O. Saad, Hassan A. Mitwally, Mohammad Al Wraidat, Asra Aroos, Nissar Shaikh, Dore C. Ananthegowda, Mohamed A. Abdelaty, Saibu George, Abdulqadir J. Nashwan, Ahmed S. Mohamed, Mohamad Y. Khatib
Format: article
Language:EN
Published: BMC 2021
Subjects:
Acute respiratory distress syndrome
COVID-19
ICU mortality
Intravenous immunoglobulin
Mechanical ventilation
Diseases of the respiratory system
RC705-779
Online Access:https://doaj.org/article/386dc40f31d34a41ab3d998b93a9a9e6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/386dc40f31d34a41ab3d998b93a9a9e6

Similar Items